096760 — JW Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapContrarian

Annual income statement for JW Holdings, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	781,515	788,937	864,536	928,072	887,710
Cost of Revenue
Gross Profit	307,278	344,179	399,959	446,157	435,219
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	711,765	720,641	766,460	820,085	711,652
Operating Profit	69,749	68,296	98,076	107,987	176,058
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	23,598	32,488	70,995	53,390	158,139
Provision for Income Taxes
Net Income After Taxes	3,385	4,435	46,482	31,026	122,788
Minority Interest
Net Income Before Extraordinary Items
Net Income	9,064	-2,778	22,152	19,026	62,618
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	9,064	-2,778	22,152	19,026	62,618
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-158	-24.8	353	559	550
Dividends per Share